Cargando…
French recommendations for the management of glycogen storage disease type III
The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364360/ https://www.ncbi.nlm.nih.gov/pubmed/37488624 http://dx.doi.org/10.1186/s40001-023-01212-5 |
_version_ | 1785076827710029824 |
---|---|
author | Wicker, Camille Cano, Aline Decostre, Valérie Froissart, Roseline Maillot, François Perry, Ariane Petit, François Voillot, Catherine Wahbi, Karim Wenz, Joëlle Laforêt, Pascal Labrune, Philippe |
author_facet | Wicker, Camille Cano, Aline Decostre, Valérie Froissart, Roseline Maillot, François Perry, Ariane Petit, François Voillot, Catherine Wahbi, Karim Wenz, Joëlle Laforêt, Pascal Labrune, Philippe |
author_sort | Wicker, Camille |
collection | PubMed |
description | The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providing tools that make the diagnosis, defining the severity and different damages of the disease by detailing tests and explorations required for monitoring and diagnosis, better understanding the different aspects of the treatment, defining the modalities and organisation of the monitoring. This is a practical tool, to which health care professionals can refer. PNDS cannot, however, predict all specific cases, comorbidities, therapeutic particularities or hospital care protocols, and does not seek to serve as a substitute for the individual responsibility of the physician in front of his/her patient. |
format | Online Article Text |
id | pubmed-10364360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103643602023-07-25 French recommendations for the management of glycogen storage disease type III Wicker, Camille Cano, Aline Decostre, Valérie Froissart, Roseline Maillot, François Perry, Ariane Petit, François Voillot, Catherine Wahbi, Karim Wenz, Joëlle Laforêt, Pascal Labrune, Philippe Eur J Med Res Review The aim of the Protocole National De Diagnostic et de Soins/French National Protocol for Diagnosis and Healthcare (PNDS) is to provide advice for health professionals on the optimum care provision and pathway for patients with glycogen storage disease type III (GSD III).The protocol aims at providing tools that make the diagnosis, defining the severity and different damages of the disease by detailing tests and explorations required for monitoring and diagnosis, better understanding the different aspects of the treatment, defining the modalities and organisation of the monitoring. This is a practical tool, to which health care professionals can refer. PNDS cannot, however, predict all specific cases, comorbidities, therapeutic particularities or hospital care protocols, and does not seek to serve as a substitute for the individual responsibility of the physician in front of his/her patient. BioMed Central 2023-07-24 /pmc/articles/PMC10364360/ /pubmed/37488624 http://dx.doi.org/10.1186/s40001-023-01212-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Wicker, Camille Cano, Aline Decostre, Valérie Froissart, Roseline Maillot, François Perry, Ariane Petit, François Voillot, Catherine Wahbi, Karim Wenz, Joëlle Laforêt, Pascal Labrune, Philippe French recommendations for the management of glycogen storage disease type III |
title | French recommendations for the management of glycogen storage disease type III |
title_full | French recommendations for the management of glycogen storage disease type III |
title_fullStr | French recommendations for the management of glycogen storage disease type III |
title_full_unstemmed | French recommendations for the management of glycogen storage disease type III |
title_short | French recommendations for the management of glycogen storage disease type III |
title_sort | french recommendations for the management of glycogen storage disease type iii |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364360/ https://www.ncbi.nlm.nih.gov/pubmed/37488624 http://dx.doi.org/10.1186/s40001-023-01212-5 |
work_keys_str_mv | AT wickercamille frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT canoaline frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT decostrevalerie frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT froissartroseline frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT maillotfrancois frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT perryariane frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT petitfrancois frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT voillotcatherine frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT wahbikarim frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT wenzjoelle frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT laforetpascal frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii AT labrunephilippe frenchrecommendationsforthemanagementofglycogenstoragediseasetypeiii |